Elanco Animal Health Incorporated
DE ˙ DB ˙ US28414H1032
20,80 € ↑0,04 (0,19%)
2026-06-05
DEL PRIS
SecurityDE:5EA / Elanco Animal Health Incorporated
InstitutionVictory Capital Management Inc
Latest Disclosed Ownership278,315 shares
Latest Disclosed Value $ 6,660,078
Victory Capital Management Inc reports 22.61% increase in ownership of 5EA / Elanco Animal Health Incorporated

On May 15, 2026 - Victory Capital Management Inc filed a 13F-HR form disclosing ownership of 278,315 shares of Elanco Animal Health Incorporated (DE:5EA) valued at $5,676,234 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 226,991 shares of Elanco Animal Health Incorporated. This represents a change in shares of 22.61% during the quarter. The current value of the position is $5,788,952 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 278,315 51,324 22.61 6,660 29.67 0.0032
2026-02-13 2025-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 226,991 8,948 4.10 5,137 16.97 0.0029
2025-11-12 2025-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 218,043 -9,087 -4.00 4,391 35.40 0.0026
2025-08-13 2025-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 227,130 -44,208 -16.29 3,243 13.83 0.0021
2025-05-02 2025-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 271,338 157,708 138.79 2,849 107.05 0.0029
2025-02-06 2024-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 113,630 11,216 10.95 1,376 -8.51 0.0014
2024-11-05 2024-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 102,414 9,480 10.20 1,504 12.16 0.0014
2024-08-05 2024-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 92,934 -5,219 -5.32 1,341 -16.03 0.0013
2024-05-03 2024-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 98,153 32,641 49.82 1,598 63.63 0.0016
2024-02-05 2023-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 65,512 11,910 22.22 976 62.13 0.0010
2023-11-06 2023-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 53,602 -201 -0.37 602 11.28 0.0007
2023-07-27 2023-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 53,803 -1,257 -2.28 541 4.64 0.0006
2023-05-02 2023-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 55,060 -223,734 -80.25 518 -84.82 0.0006
2023-04-25 2022-12-31 13F/A-3 ELANCO ANIMAL HEALTH COM 28414H103 278,794 33,635 13.72 3,407 11.97 0.0039
2023-03-10 2022-12-31 13F/A-2 ELANCO ANIMAL HEALTH COM 28414H103 278,794 33,635 3,407 0.0024
2023-02-10 2022-12-31 13F/A-1 ELANCO ANIMAL HEALTH COM 28414H103 278,794 33,635 3,407 0.0023
2023-02-09 2022-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 278,310 33,151 3,481 0.0024
2022-11-02 2022-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 245,159 31,324 14.65 3,042 -27.54 0.0036
2022-08-01 2022-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 213,835 39,129 22.40 4,198 -7.06 0.0048
2022-05-04 2022-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 174,706 -71,844 -29.14 4,517 -35.44 0.0045
2022-02-07 2021-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 246,550 -2,226 -0.89 6,997 -11.80 0.0064
2021-11-02 2021-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 248,776 -6,760 -2.65 7,933 -10.50 0.0078
2021-08-03 2021-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 255,536 4,349 1.73 8,864 19.83 0.0085
2021-05-04 2021-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 251,187 108,721 76.31 7,397 69.31 0.0076
2021-02-01 2020-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 142,466 -40,752 -22.24 4,369 -14.62 0.0049
2020-11-09 2020-09-30 13F Elanco Animal Health COM 28414H103 183,218 27,582 17.72 5,117 53.30 0.0066
2020-08-07 2020-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 155,636 -82,605 -34.67 3,338 -37.42 0.0045
2020-05-12 2020-03-31 13F/A-1 ELANCO ANIMAL HEALTH COM 28414H103 238,241 -29,532 -11.03 5,334 -32.36 0.0089
2020-05-04 2020-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 238,241 -29,532 5,334 5,837.5210
2020-02-06 2019-12-31 13F/A-1 ELANCO ANIMAL HEALTH COM 28414H103 267,773 13,090 5.14 7,886 16.45 0.0096
2020-02-04 2019-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 267,082 12,399 8,253 9,892.7939
2019-11-12 2019-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 254,683 254,683 6,772 0.0087
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.